Physician

Ahmed H Jafri, M.D.

According to 2025 Medicare claims, Ahmed Jafri, M.D. (NPI: 1376597815) practices neurology, with the plurality of this provider's patient population coming from Williamson, IL. This provider's primary affiliated billing organization is SOUTHERN ILLINOIS MEDICAL SERVICES, NFP (NPI: 1770656837; TIN: 205521741) and primary practice location at 62901-1474. Jafri is affiliated with the IRCCO (ACO ID: A2619), IHCI ACO Midwest LLC (ACO ID: A5516), and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Jafri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 272 traditional Medicare patients, billed 3,256 HCPCS/CPT codes, and received $49,221 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,573 prescription claims across 354 beneficiaries totaling $757,769 in drug costs, led by Kesimpta Pen (Ofatumumab). Open Payments data shows 55 records totaling $952. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $40,371 and ending at $49,221. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	243	542	$40,371
2016	180	604	$27,220
2017	154	5,323	$45,266
2018	317	3,906	$67,204
2019	336	2,000	$59,851
2020	352	3,813	$59,231
2021	359	4,078	$70,382
2022	252	2,037	$44,058
2023	248	2,619	$45,785
2024	272	3,256	$49,221

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	100	746	$480,023
2016	101	656	$541,846
2017	81	601	$635,038
2018	132	526	$302,376
2019	166	890	$204,958
2020	234	1,408	$342,654
2021	287	1,895	$589,264
2022	295	2,117	$580,371
2023	337	2,421	$688,719
2024	354	2,573	$757,769

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	39	50	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	82	$94
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	41	41	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	122	155	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	171	229	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	35	1,004	$344,493
Aimovig Autoinjector	Erenumab-Aooe	113	3,194	$83,550
Austedo	Deutetrabenazine	11	330	$65,569
Nurtec Odt	Rimegepant Sulfate	44	686	$47,579
Ubrelvy	Ubrogepant	29	651	$29,392

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$952	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmed H. Jafri, M.D.?

Tedicare shows public-source Medicare data for Ahmed H. Jafri, M.D. (NPI 1376597815), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed H. Jafri, M.D. have ACO affiliation data?

Ahmed H. Jafri, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), IHCI ACO Midwest LLC (MSSP, ACO ID A5516), and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Ahmed H. Jafri, M.D.?

Ahmed H. Jafri, M.D. is linked to SOUTHERN ILLINOIS MEDICAL SERVICES, NFP (billing NPI 1770656837) in the available physician profile data.

Does Ahmed H. Jafri, M.D. have Open Payments data?

Ahmed H. Jafri, M.D. has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.